FDA is looking for regulatory flexibilities to help support medical supply chain resiliency, officials told Inside Health Policy at a conference hosted by the Association for the Advancement of Medical Instrumentation (AAMI) Wednesday (Feb. 21). Tammy Beckham, associate director of the resilient supply chain and shortages prevention program in FDA’s Center for Devices and Radiological Health, said FDA wants to find new opportunities for the agency to provide guidance and flexibility to manufacturers to help avoid shortages. “One of...